• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    5/24/24 9:13:37 AM ET
    $HQL
    Investment Managers
    Finance
    Get the next $HQL alert in real time by email
    DEFA14A 1 tm2415427d1_defa14a.htm DEFA14A

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No.         )

     

    Filed by the Registrant     [X]

     

    Filed by a Party other than the Registrant     [   ]

     

    Check the appropriate box:

     

    [   ]Preliminary Proxy Statement
    [   ]Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    [   ]Definitive Proxy Statement
    [X]Definitive Additional Materials
    [   ]Soliciting Material under §240.14a-12

     

    abrdn Life Sciences Investors

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    [X]No fee required.
    [   ]Fee paid previously with preliminary materials.
    [   ]Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(l) and 0-11.

     

     

     

     

    abrdn Life Sciences Investors (NYSE: HQL)
    (formerly Tekla Life Sciences Investors)

     

     

    Shareholder Services

     

     

     

    Text Box: IMPORTANT NOTICE

     

    Re: abrdn Life Sciences Investors (NYSE: HQL) formerly Tekla Life Sciences Investors

     

    Dear Shareholder:

     

    We have tried unsuccessfully to contact you, whether by mail or by phone, regarding a very important matter concerning your investment with abrdn Life Sciences Investors (formerly Tekla Life Sciences Investors). This matter pertains to important operating initiatives for the Fund for which we need your consideration and response.

     

    It is very important that we speak to you regarding this matter. Please call toll-free at 1-800-967-7574 between 9:00 a.m. and 10:00 p.m. Eastern Time, Monday through Friday. At the time of the call, please reference the Investor ID listed below.

     

    INVESTOR PROFILE:

     

    Investor ID:  XXXXXXXX  Security ID:  XXXXXXXX
    Shares owned:  XXXXXXXXX  Household ID:  XXXXXXXX 

     

    There is no confidential information required and the call will only take a few moments of your time. Please contact us as soon as possible. Thank you for your time and consideration.

     

    Sincerely,

     

    Megan Kennedy

    Vice President and Secretary

     

     

     OFFICIAL BUSINESS  This document relates to your investment in abrdn Life Sciences Investors (formerly Tekla Life Sciences Investors).

     

     

    Get the next $HQL alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HQL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HQL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Maher Bill bought $9,990 worth of shares (650 units at $15.37) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      8/27/24 2:46:40 PM ET
      $HQL
      Investment Managers
      Finance
    • Director Dimartino Rose bought $15,530 worth of shares (1,000 units at $15.53) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      7/18/24 2:56:19 PM ET
      $HQL
      Investment Managers
      Finance
    • Large owner Saba Capital Management, L.P. bought $1,407 worth of shares (100 units at $14.07) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      6/27/24 11:22:29 AM ET
      $HQL
      Investment Managers
      Finance

    $HQL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF)  (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025).   These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).

      6/30/25 4:17:00 PM ET
      $ASGI
      $HQH
      $HQL
      $IAF
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

      PHILADELPHIA, May 28, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on May 28, 2025.  At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Asia-Pacific Income Fund, Inc.  ("FAX")As of the record date, April 7, 2025, FAX had outstanding 41,282,628 shares of common stock and 4,000,000 shares of preferred stock. 60.36% of outstanding common stock and 100% of preferred stock were voted representing a quorum. To elect one Clas

      5/28/25 6:13:00 PM ET
      $ACP
      $AEF
      $AGD
      $AOD
      Investment Managers
      Finance
      Finance/Investors Services
      Trusts Except Educational Religious and Charitable
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies

    $HQL
    SEC Filings

    See more
    • SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest

      N-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)

      6/9/25 2:15:52 PM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form N-CEN filed by abrdn Life Sciences Investors Shares of Beneficial Interest

      N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)

      12/16/24 11:48:20 AM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form N-CSR filed by abrdn Life Sciences Investors Shares of Beneficial Interest

      N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)

      12/9/24 1:05:51 PM ET
      $HQL
      Investment Managers
      Finance

    $HQL
    Leadership Updates

    Live Leadership Updates

    See more
    • abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

      PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

      3/21/24 7:59:00 AM ET
      $AWP
      $HQH
      $HQL
      $THQ
      Trusts Except Educational Religious and Charitable
      Finance
      Finance Companies
      Investment Managers

    $HQL
    Financials

    Live finance-specific insights

    See more
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF)  (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025).   These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).

      6/30/25 4:17:00 PM ET
      $ASGI
      $HQH
      $HQL
      $IAF
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

      PHILADELPHIA, May 28, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on May 28, 2025.  At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Asia-Pacific Income Fund, Inc.  ("FAX")As of the record date, April 7, 2025, FAX had outstanding 41,282,628 shares of common stock and 4,000,000 shares of preferred stock. 60.36% of outstanding common stock and 100% of preferred stock were voted representing a quorum. To elect one Clas

      5/28/25 6:13:00 PM ET
      $ACP
      $AEF
      $AGD
      $AOD
      Investment Managers
      Finance
      Finance/Investors Services
      Trusts Except Educational Religious and Charitable
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies

    $HQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Dietrick Joseph Francis

      3 - abrdn Life Sciences Investors (0000884121) (Issuer)

      7/22/25 2:40:32 PM ET
      $HQL
      Investment Managers
      Finance
    • Large owner Saba Capital Management, L.P. sold $145,135 worth of shares (11,419 units at $12.71) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      5/22/25 6:22:54 PM ET
      $HQL
      Investment Managers
      Finance
    • Large owner Saba Capital Management, L.P. sold $286,646 worth of shares (23,729 units at $12.08) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      5/19/25 6:47:05 PM ET
      $HQL
      Investment Managers
      Finance

    $HQL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

      6/3/24 9:15:41 AM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

      4/29/24 10:52:45 AM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

      4/17/24 8:32:11 AM ET
      $HQL
      Investment Managers
      Finance